We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Requests Patent Extension for Transplant Drug Myfortic
Novartis Requests Patent Extension for Transplant Drug Myfortic
June 21, 2011
Novartis is seeking an extension of the ’900 patent covering its transplant drug Myfortic based on the FDA’s lengthy review time.